News about PaperPanda, Open Access, and Research
US vaccine maker Moderna expressed confidence Monday that its booster shot was effective against the Omicron variant, after the announcement of laboratory results it described as “reassuring”. “We’ll be able to rely on this vaccine to address the near term surge of Omicron cases,” Stephen Hoge, president of Moderna, said on a conference call. … Read more
By Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper, Jason Arunn Murugesu and Layal Liverpool A Swiss soldier closes the curtain of a booth prior to the administration of a Moderna covid-19 booster jab in Switzerland. FABRICE COFFRINI/AFP via Getty Images Latest coronavirus news as of 1pm on … Read more
By Michael Le Page and Graham Lawton People queue for vaccinations at St Thomas’ Hospital in London Dan Kitwood/Getty Images The world is facing a surge in hospitalisations and deaths from the omicron variant of the coronavirus that could be as bad as in previous waves, even if omicron is only a third as severe … Read more
Vaccine-makers are already adapting vaccines to fight the omicron coronavirus variant, but it will probably already have swept the world by the time these arrive Health | Analysis 30 November 2021 By Michael Le Page A health worker holds a vial of the Pfizer/BioNTech vaccine CHAMILA KARUNARATHNE/EPA-EFE/Shutterstock Is omicron better at evading existing vaccines than … Read more
US biotech company Moderna on Friday announced promising data from an early-stage human trial of its mRNA flu shot, based on the same technology used in its successful COVID-19 vaccine. The experimental flu shot was found to be safe, and successfully evoked high levels of antibodies in 180 people at all dosage levels, in … Read more